KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Gross Profit (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Gross Profit data on record, last reported at $943.8 million in Q4 2025.

  • For Q4 2025, Gross Profit fell 10.28% year-over-year to $943.8 million; the TTM value through Dec 2025 reached $3.6 billion, up 16.76%, while the annual FY2025 figure was $3.6 billion, 1.08% down from the prior year.
  • Gross Profit reached $943.8 million in Q4 2025 per CRL's latest filing, up from $927.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $2.5 billion in Q4 2023 and bottomed at $353.7 million in Q2 2024.
  • Average Gross Profit over 5 years is $799.5 million, with a median of $806.1 million recorded in 2021.
  • Peak YoY movement for Gross Profit: surged 305.34% in 2022, then crashed 57.6% in 2024.
  • A 5-year view of Gross Profit shows it stood at $437.0 million in 2021, then soared by 305.34% to $1.8 billion in 2022, then surged by 40.08% to $2.5 billion in 2023, then plummeted by 57.6% to $1.1 billion in 2024, then decreased by 10.28% to $943.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $943.8 million in Q4 2025, $927.2 million in Q3 2025, and $922.1 million in Q2 2025.